Besides, selective sensitivity to blockade of the de novo purine synthesis pathway is revealed in the variant subtype of SCLC [81], though the mechanism on how the variant subtype of SCLC exhibits sensitivity toward DHODH inhibition remains to be further elucidated [41]. Here, DHODH is linked to small cell lung carcinoma.